App4Independence (A4i) is an app and web portal to support people with schizophrenia and psychosis, and is being developed in a joint venture between CAMH and MEMOTEXT Corporation. The mobile and web-based platform provides patient-informed tools, including medication and appointment reminders, evidence-based strategies to cope with symptoms, and peer-to-peer support. The platform will undergo broad user testing as the next step.
Initial beta testing by users has been completed.
A patent application was filed for the app’s auditory hallucination detector.
A nutraceutical to prevent postpartum depression
Dr. Jeffrey Meyer has developed a natural health product with a unique combination of ingredients that replenishes essential brain chemicals to boost mood after childbirth. This CAMH-developed formulation is safe for use by breastfeeding mothers, and is now being studied in a randomized controlled trial.
A U.S. patent was issued
A new company, Venessance Innovations Inc., was create
A large market research survey was completed, with highly favourable results.
Help us change mental health care forever.
Your donation moves us closer to a future where no one is left behind.